Codexis

Отрасль

Промышленная химия

Темы

Ферменты и биокатализ

Роль

Производитель — “…proteins for pharmaceutical manufacturing and diagnostic applications. Founded in 2002, the company utilizes i…”

Почему это биоэкономика

Codexis конструирует ферменты для фармацевтического биокатализа и производства РНК.

Пока не указана поставщиком в решениях с доказательствами.

• 2026-09-28 Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA :: Codexis, Inc. (CDXS)
  Codexis announces a collaboration with a leading siRNA drug innovator to use its ECO Synthesis platform for enzymatic, stereo-defined fragment synthesis and ligation into final siRNA duplexes, comparing with solid-phase methods to assess purity and quality. …
• 2026-08-12 Codexis Reports Second Quarter 2026 Financial Results - BioSpace
  Codexis reported Q2 2026 revenue of $14.9 million, reiterated full-year guidance (revenues $72–$76 million; gross margin high‑60s%), and healthy cash runway (pro forma ~$80 million after a July $25 million equity raise). The company highlighted progress …
• 2026-08-03 Codexis Appoints David Butler, PhD, to Strategic Advisory
  Codexis is expanding its strategic leadership by adding David Butler, PhD, to its Strategic Advisory Board, signaling a focus on advancing siRNA therapeutics and industrializing its enzymatic technology for scalable manufacturing. The company also acknowledges …
• 2026-07-24 Codexis Prices $23.1M Public Offering | GenomeWeb
  Codexis is raising about $23.1 million from a public stock offering at $1.50 per share (approximately 16.7 million shares with an option for up to 2.5 million more), to fund working capital, R&D, and general corporate purposes; the company also reports solid …
• 2026-08-03 Codexis Appoints David Butler, PhD, to Strategic Advisory
  Codexis is expanding its strategic leadership by adding David Butler, PhD, to its Strategic Advisory Board to bolster its growth and expertise in siRNA therapeutics and scalable enzymatic manufacturing, while thanking Carole Cobb for her contributions as she …
• 2026-03-04 Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing Platform

Похожие компании

Genencor · Amyris · EDT-Enzymatic Deinking Technologies, LLC · Jeneil Biotech, Inc. · Dyadic Applied BioSolutions · Yzymes · Protein Evolution · Mascoma LLC